Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hsu S Ginseng Enterprises
WARNING LETTER
•Hsu S Ginseng Enterprises•December 3, 2010

Hsu S Ginseng Enterprises – FDA Warning Letter, Dec 3, 2010

Record Details

The FDA issued a Warning Letter to Hsu's Ginseng Enterprises, Inc. following an inspection from November 30 to December 3, 2010, at their Wausau, Wisconsin facility. A sample of their "Root to Health, American Ginseng, Herbal Supplement" was found to be adulterated under 21 U.S.C. § 342(a)(2)(B) due to the presence of unsafe pesticide chemical residues, Chlorpyrifos and Pentachlorobenzonitrile, for which no tolerance or exemption exists (21 U.S.C. § 346a).

The inspection also identified several deficiencies in Current Good Manufacturing Practice (CGMP) regulations for Dietary Supplements (21 CFR Part 111). These included a lack of finished product release specifications for ginseng encapsulated products regarding identity, strength, purity, composition, or contamination limits (21 CFR 111.70(e)). Training records were incomplete, missing details such as who was trained, topics, trainer, course length, and successful completion (21 CFR 111.12(c)). Additionally, batch records for American Ginseng and Bee Pollen & American Ginseng supplements were unavailable (21 CFR 111.610(a) and (b)). The firm was also cited for using unsupported expiration dates on product labels.

Hsu's Ginseng is required to take prompt corrective action and notify the FDA in writing within 15 working days, detailing steps taken to prevent recurrence and providing supporting documentation. Failure to comply may result in regulatory actions, including product seizure or injunction.

Company
Hsu S Ginseng Enterprises
Inspection date
December 3, 2010
Product type
Food
Office
Minneapolis District Office
Person
  • Gerald J. Berg
View Company Profile

ID · 349093e5-8705-4302-9985-dedfc64694a6

Violation Codes7
21 U.S.C. 342(a)(2)(B)21 U.S.C. 346a21 CFR 11121 CFR 111.70(e)21 CFR 111.12(c)21 CFR 111.610(a)21 CFR 111.610(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hsu S Ginseng Enterprises
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.